MCK 📈 McKesson - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58155Q1031

MCK: Pharmaceuticals, Medical Supplies, Technology Solutions, Logistics Services

Mckesson Corporation is a multinational healthcare company that provides a wide range of services and products to the healthcare industry in the United States and internationally. The company operates through four distinct segments, each catering to different aspects of the healthcare ecosystem. The U.S. Pharmaceutical segment is a key player in the distribution of pharmaceutical drugs, including branded, generic, specialty, biosimilar, and over-the-counter medications, as well as other healthcare-related products. This segment also offers an array of services to community-based oncology and specialty practices, such as practice management, technology, clinical support, and business solutions, enabling these practices to streamline their operations and improve patient care.

The Prescription Technology Solutions (RxTS) segment is focused on addressing medication challenges by connecting patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. This segment provides innovative solutions to facilitate access to medication, including prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. By working across the healthcare landscape, RxTS helps to ensure that patients receive the medications they need to manage their health effectively. Additionally, this segment serves biopharma and life sciences partners, supporting the development and delivery of new treatments and therapies.

The Medical-Surgical Solutions segment offers a comprehensive range of medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment plays a critical role in ensuring that healthcare providers have access to the medical supplies and equipment they need to deliver high-quality patient care. By providing efficient distribution and logistics services, McKesson helps to reduce costs and improve the overall efficiency of the healthcare system.

The International segment is responsible for providing distribution and services to wholesale, institutional, and retail customers in Europe and Canada. This segment enables McKesson to expand its reach and support the healthcare needs of patients and providers in these regions. With a rich history dating back to 1833, McKesson Corporation has established itself as a trusted and reliable partner in the healthcare industry, with a strong commitment to improving the health and wellbeing of people around the world. The company is headquartered in Irving, Texas, and its common stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol MCK, with the ISIN code US58155Q1031, and is classified under the GICS Sub Industry of Health Care Distributors.

Additional Sources for MCK Stock

MCK Stock Overview

Market Cap in USD 73,199m
Sector Healthcare
Industry Medical Distribution
GiC Sub-Industry Health Care Distributors
IPO / Inception 1994-11-15

MCK Stock Ratings

Growth 5y 90.9%
Fundamental 49.6%
Dividend 60.2%
Rel. Strength Industry 605
Analysts 4.35/5
Fair Price Momentum 674.90 USD
Fair Price DCF 957.50 USD

MCK Dividends

Dividend Yield 12m 0.45%
Yield on Cost 5y 1.76%
Annual Growth 5y 9.89%
Payout Consistency 94.5%

MCK Growth Ratios

Growth Correlation 3m 39.5%
Growth Correlation 12m 42%
Growth Correlation 5y 98.7%
CAGR 5y 31.16%
CAGR/Mean DD 5y 5.82
Sharpe Ratio 12m 0.71
Alpha 2.73
Beta 0.73
Volatility 21.10%
Current Volume 590.2k
Average Volume 20d 720.2k
What is the price of MCK stocks?
As of January 14, 2025, the stock is trading at USD 585.08 with a total of 590,187 shares traded.
Over the past week, the price has changed by +0.80%, over one month by +1.53%, over three months by +15.01% and over the past year by +20.33%.
Is McKesson a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, McKesson (NYSE:MCK) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 49.59 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MCK as of January 2025 is 674.90. This means that MCK is currently undervalued and has a potential upside of +15.35% (Margin of Safety).
Is MCK a buy, sell or hold?
McKesson has received a consensus analysts rating of 4.35. Therefor, it is recommend to buy MCK.
  • Strong Buy: 10
  • Buy: 3
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
What are the forecast for MCK stock price target?
According to ValueRays Forecast Model, MCK McKesson will be worth about 741.1 in January 2026. The stock is currently trading at 585.08. This means that the stock has a potential upside of +26.67%.
Issuer Forecast Upside
Wallstreet Target Price 654 11.8%
Analysts Target Price 486.3 -16.9%
ValueRay Target Price 741.1 26.7%